Adaptango Performance PRocess for Older Adults Community reHabilitation

NCT ID
NCT07824128
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Emory University
Conditions
Mild Cognitive Impairment, Old Age; Dementia, Parkinson Disease

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Community-based Participatory Evaluation Studies on a Partnered Dance Program for Adults With Neurodegenerative Disease

Enrollment: 120 participants (Estimated).

What is being studied

  • Other: Adaptango Performance Process (APP) program

Who may be eligible

Ages
18 Years to no maximum
Sex
All
Healthy volunteers accepted
Yes

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Individuals (PWP, younger adults, PLwD) from the greater Atlanta area. Those in the PWP group must be diagnosed by a neurologist specialized in Parkinson's disease. * Score of at least 18 on the Montreal Cognitive Assessment (MoCA). Those who are in the PLwD group must score between 18 and 25 on the MoCA. Exclusion Criteria: * Acute medical illness requiring hospitalization * Uncontrolled congestive heart failure * History of stroke in the past three years * Inability to perform study procedures * Medical or physical conditions that would preclude participation (e.g., severe arthritis or mobility problems, uncontrolled hypertension or diabetes, renal failure, history of angina with activity) * Taking medications that could adversely affect cognition, e.g., antipsychotics, opioids, stimulants, chemotherapy, neurologic prescriptions to treat Multiple sclerosis. When applicable, enrollment will be delayed until dosages are stable on, e.g., Aricept, Namenda, anticholinesterase inhibitors, for at least 3 months * Psychotic disorders * Confounding neurologic conditions \[e.g., active central nervous system (CNS) opportunistic infections, seizure disorders, head injury with loss of consciousness \>30 minutes, intracranial neoplasms, stroke with neurological or neuropsychiatric sequelae\] * Substance Use Disorder, Major Depressive Disorder, and Generalized Anxiety Disorders within six months of evaluation * Unable to provide informed consent * Cognitively impaired individuals or individuals with impaired decision-making, individuals who are not yet adults, pregnant women, prisoners * Not able to clearly understand English

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • Georgia, United States: 1

Sample of listed locations

  • Emory University, Executive Park, Wesley Woods — Atlanta, Georgia, 30329, United States — Site recruitment status not specified in the registry data

Study details

Start date
October 1, 2026
Primary completion date
September 1, 2029
Completion date
September 1, 2029
First posted
September 17, 2026
Collaborators
National Endowment for the Arts, United States

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07824128
Registry last updated
September 17, 2026
QualifiedStudies registry data refreshed
September 28, 2026
QualifiedStudies record fetched
September 28, 2026

View NCT07824128 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Alzheimers Disease studies | Clinical trial FAQ